2 Top Healthcare Stocks to Buy for the Long Haul
Amgen (NASDAQ: AMGN) and Vertex Pharmaceuticals (NASDAQ: VRTX) run the gamut of biotech stocks. Amgen is more established and has a dividend, while Vertex is one of several companies looking for therapies using the CRISPR Cas/9 gene-editing technique, which won the Nobel Prize just two years ago.
What both stocks have in common, though, is that they're up while most other biotech stocks are taking a hit this year. That's because both companies are profitable with growing revenue and have shown the ability to expand their base of therapies.
Amgen helped pioneer biotechnology and sells its therapies in more than 100 countries. It's that rare biotech stock that's a value stock because of its size and dividend. It focuses on novel and biosimilar therapies in oncology, bone health, inflammation, cardiovascular disease, nephrology, and neuroscience.
Source Fool.com
